New compound halves jet lag recovery in mice

Scientists have developed a compound called Mic-628 that advances the body's internal clock, potentially easing jet lag. In tests on mice, a single dose reduced adjustment time to a shifted schedule from seven days to four. The discovery targets a key protein to synchronize rhythms across the body.

A team of Japanese researchers has identified Mic-628, a compound that reliably shifts the mammalian circadian clock forward. Led by Emeritus Professor Tei H. from Kanazawa University, along with Associate Professor Takahata Y. from Osaka University, Professor Numano R. from Toyohashi University of Technology, and Associate Professor Uriu K. from the Institute of Science Tokyo, the group published their findings in the Proceedings of the National Academy of Sciences.

Mic-628 works by binding to the CRY1 protein, which typically inhibits clock gene activity. This binding promotes the formation of a molecular complex involving CLOCK, BMAL1, CRY1, and the compound itself. The complex then activates the Per1 gene at a specific DNA site known as the dual E-box, jump-starting daily biological rhythms. This mechanism synchronizes the brain's master clock in the suprachiasmatic nucleus with peripheral clocks in organs like the lungs, and it functions independently of dosing time.

To assess practical benefits, the researchers simulated jet lag in mice by advancing the light-dark cycle by six hours. Untreated mice took seven days to adapt, but those given a single oral dose of Mic-628 adjusted in just four days. Mathematical modeling confirmed that a feedback loop with the PER1 protein stabilizes this forward shift.

Advancing the clock—needed for eastward travel or early shifts—proves challenging compared to delaying it. Traditional methods like light therapy or melatonin require precise timing and yield inconsistent results. Mic-628's timing-independent action marks a novel pharmacological strategy.

Future studies will evaluate its safety and efficacy in more animal models and humans, positioning it as a potential treatment for jet lag, shift-work sleep issues, and circadian disorders.

Relaterede artikler

Laboratory photo of a scientist studying mouse brain samples with scans showing Alzheimer's research progress on circadian clock proteins.
Billede genereret af AI

Blocking a circadian clock protein boosts brain NAD+ and curbs tau in mice

Rapporteret af AI Billede genereret af AI Faktatjekket

Washington University scientists report that inhibiting the circadian regulator REV-ERBα raised brain NAD+ and reduced tau pathology in mouse models, pointing to a clock-focused strategy worth exploring for Alzheimer’s disease.

Researchers at Washington University School of Medicine in St. Louis report that amyloid pathology in mouse models of Alzheimer’s disease disrupts circadian rhythms in microglia and astrocytes, altering the timing of hundreds of genes. Published October 23, 2025, in Nature Neuroscience, the study suggests that stabilizing these cell-specific rhythms could be explored as a treatment strategy.

Rapporteret af AI

Scientists at Cold Spring Harbor Laboratory have found that breast cancer quickly disrupts the brain's internal clock in mice, flattening daily stress hormone cycles and impairing immune responses. Remarkably, restoring these rhythms in specific brain neurons shrank tumors without any drugs. The discovery highlights how early physiological imbalances may worsen cancer outcomes.

A research team from the University of Rochester, Harvard Medical School, and Boston Children’s Hospital reports that an inclusion-complex nano‑micelle formulation of cannabidiol, called CBD‑IN, rapidly reduced neuropathic pain in mice and did so without detectable balance, movement, or memory problems. The study, published online ahead of print in Cell Chemical Biology on November 7, 2025, suggests the effect did not depend on the classic CB1 or CB2 cannabinoid receptors.

Rapporteret af AI

Researchers at Ben-Gurion University have identified the protein SIRT6 as a key regulator of tryptophan metabolism in the brain, explaining how its loss leads to toxic byproducts in aging and diseased brains. The study reveals that declining SIRT6 shifts tryptophan toward harmful pathways, reducing protective neurotransmitters like serotonin and melatonin. Blocking a related enzyme showed potential for reversing brain damage in models.

Researchers at the National University of Singapore have discovered that calcium alpha-ketoglutarate, a naturally occurring molecule, can repair key memory processes disrupted by Alzheimer's disease. The compound improves communication between brain cells and restores early memory abilities that fade first in the condition. Since it already exists in the body and declines with age, boosting it could offer a safer approach to protecting brain health.

Rapporteret af AI Faktatjekket

Older adults with weaker or more irregular daily rest-activity rhythms were more likely to be diagnosed with dementia over about three years, according to a study published in *Neurology*. The research also linked later-afternoon activity peaks to higher dementia risk, though it did not establish that disrupted circadian rhythms cause dementia.

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis